EU/3/07/472: Orphan designation for the treatment of chronic non-infectious uveitis
Cyclo {{(E,Z)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)nona-6,8-dienoyl}-L-2-aminobutyryl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl}
Overview
Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in November 2012 on request of the sponsor.
On 14 September 2007, orphan designation (EU/3/07/472) was granted by the European Commission to Lux Biosciences GmbH, Germany, for cyclo {{(E,Z)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)nona-6,8-dienoyl}-L-2-aminobutyryl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl} for the treatment of chronic non-infectious uveitis.
For a list of the administrative updates to this public summary of opinion please refer to the PDF document below.
Key facts
Active substance |
Cyclo {{(E,Z)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)nona-6,8-dienoyl}-L-2-aminobutyryl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl}
|
Intended use |
Treatment of chronic non-infectious uveitis
|
Orphan designation status |
Withdrawn
|
EU designation number |
EU/3/07/472
|
Date of designation |
14/09/2007
|
Sponsor |
Lux Biosciences GmbH
Dreieichstr. 59 D-60594 Frankfurt am Main Germany Tel. + 49 69 5050 65 991 Fax + 49 69 5050 65 980 E-mail: info@luxbio.de |
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.
EU register of orphan medicines
The list of medicines that have received an orphan designation in the EU is available on the European Commission's website: